Drug Companies More Likely to Keep R&D In-House When Patents Are at Stake, UMass Amherst-Cornell Study Finds
April 29, 2026
April 29, 2026
AMHERST, Massachusetts, April 29 -- The University of Massachusetts posted the following news:
* * *
Drug Companies More Likely to Keep R&D In-House When Patents Are at Stake, UMass Amherst-Cornell Study Finds
*
Drug companies are more likely to keep research and development (R&D) in-house, rather than outsource it, when they already have patented drugs on the market in the same therapeutic area, and especially when those patents still . . .
* * *
Drug Companies More Likely to Keep R&D In-House When Patents Are at Stake, UMass Amherst-Cornell Study Finds
*
Drug companies are more likely to keep research and development (R&D) in-house, rather than outsource it, when they already have patented drugs on the market in the same therapeutic area, and especially when those patents still . . .